Position in FATE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$507,569
+$419,975 QoQ
Shares Held
187,989
+157.5% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. FATE ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in FATE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $507,569 | 187,989 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $87,594 | 72,996 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $302,370 | 308,542 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $265,213 | 210,487 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $507,439 | 453,072 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $290,155 | 367,285 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $687,605 | 416,731 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,482,637 | 424,277 | Shares | Sole | 2024-11-19 | |
| 2024-06-30 | $403,071 | 122,888 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,379,942 | 324,243 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,341,569 | 359,375 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $251,751 | 118,751 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,280,511 | 479,099 | Shares | Sole | 2023-09-20 | |
| 2023-03-31 | $2,854,684 | 500,822 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,662,498 | 263,875 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,009,484 | 178,915 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $515,844 | 20,817 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $829,599 | 21,398 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,214,814 | 106,218 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,244,912 | 54,748 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,692,392 | 42,544 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,051,278 | 109,779 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $11,807,169 | 129,849 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,354,870 | 158,991 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,688,598 | 136,654 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,433,593 | 109,572 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||